文献速递免疫规划传染病防控与疫情报告

新冠RBD与脑膜炎球菌抗原双靶点免疫诱导小鼠功能性中和与杀菌抗体

Functional neutralizing and bactericidal antibody responses induced by dual-target immunization with SARS-CoV-2 RBD and Neisseria meningitidis antigens in mice.
PubMed 文献 · Vaccine · 2026-08-12

研究用SARS-CoV-2受体结合域(RBD)联合脑膜炎奈瑟菌外膜囊泡(OMV)及氢氧化铝佐剂免疫BALB/c小鼠,通过病毒中和试验、血清杀菌试验和免疫印迹评估抗体功能。结果显示免疫小鼠产生高滴度中和抗体和杀菌抗体,可识别58至80 kDa的奈瑟菌抗原,且子代IgG模式与母鼠一致,表明该免疫策略可诱导针对两种病原体的功能性抗体。

要点

  • RBD+OMV+AH免疫小鼠产生高滴度SARS-CoV-2中和抗体和脑膜炎球菌杀菌抗体。
  • 抗体可识别58至80 kDa的奈瑟菌抗原。
  • 子代IgG抗体模式与母鼠一致,提示抗体可转移至后代。

核心结论

  • RBD联合OMV及氢氧化铝佐剂的双靶点免疫可诱导针对SARS-CoV-2和脑膜炎奈瑟菌的功能性抗体。

研究设计与样本

  • BALB/c小鼠免疫研究,使用SARS-CoV-2 RBD混合脑膜炎奈瑟菌OMV及氢氧化铝佐剂。

主要发现

  • 免疫小鼠血清中和抗体和杀菌抗体滴度高。
  • 抗体识别奈瑟菌58至80 kDa抗原。
  • 子代IgG检测模式与母鼠一致。

临床怎么用

  • 提示双靶点疫苗设计可能同时预防COVID-19和脑膜炎球菌病,但尚需进一步临床前和临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vaccination can elicit functional antibodies to reduce the burden of infectious diseases, such as neutralizing antibodies (nAbs) to control COVID-19, and bactericidal antibodies to prevent meningococcal disease. BALB/c mice were immunized with the receptor binding domain (RBD) from SARS-CoV-2, mixed with outer membrane vesicles (OMVs) from N. meningitidis and Aluminum hydroxide, resulting in a simultaneous immune response to SARS-CoV-2 and meningococci, and IgG transference to the offspring, as published in a previous article. In this brief communication, antibodies' function was assessed by cytopathic effect-based virus neutralization test, serum bactericidal assay and immunoblotting. Mice immunized with RBD + OMV + AH presented high nAbs and bactericidal titers, which recognized Neisseria antigens from 58 to 80 kDa. IgG detected on the offspring followed the same pattern of mothers. The results suggest that the immunization approach induced functional antibodies to both pathogens.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Portilho AI, Andreata-Santos R, Duarte-Barbosa M, et al. Functional neutralizing and bactericidal antibody responses induced by dual-target immunization with SARS-CoV-2 RBD and Neisseria meningitidis antigens in mice. Vaccine. 2026. PMID: 42585813. doi:10.1016/j.vaccine.2026.129011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。